NIH Postdoctoral Fellowships in Addiction Research
Bethesda, Maryland, US
The Laboratory of Clinical and Translational Studies (LCTS) at the National Institute on Alcohol Abuse and Alcoholism (NIAAA), one of the National Institutes of Health (NIH), Department of Health and Human Services (DHHS), is recruiting for post-doctoral fellows (MD and/or PhD) to conduct research in the laboratory located within the Mark O Hatfield Clinical Research Center on the main NIH campus in Bethesda, MD. The laboratory uses translational strategies and human studies, to investigate genetic susceptibility and neuroadaptive processes underlying the development of alcohol dependence and related phenotypes. The lab also conducts studies aimed at identifying potential molecular and behavioral targets for novel treatments. Current research opportunities are available at:
o Section on Molecular Pathophysiology (MP) conducts basic science that is aimed at discovering novel molecular targets for treatment of alcoholism. The discovery work of the Section typically starts out with rodent models of alcoholism and related behaviors, such as anxiety and stress responses. The Section uses rat and mouse paradigms to model excessive voluntary alcohol intake and relapse to alcohol seeking triggered by stress. Various methods are used to screen for differential gene expression within brain areas important for negative emotions and stress, in order to discover candidate treatment targets. These are confirmed through quantitative expression analysis and anatomical mapping. The functional role of confirmed candidate targets is finally examined by going back to the animal models. Candidates (MD and/or PhD) should be individuals with a strong background and interest in behavioral neuroscience. For additional information, contact: Dr. Markus Heilig firstname.lastname@example.org
o Section on Clinical Psychoneuroendocrinology and Neuropsychopharmacology (CPN) is a joint NIAAA-NIDA section, whose mission is to identify new pharmacological targets for addictions treatment and develop new medications for alcoholism and smoking. Research includes outpatient and inpatient studies (including human laboratory studies with neuroimaging and biobehavioral components) with a special emphasis on the possible role of feeding-related hormones as novel pharmacological targets for medications development. Candidates (MD and/or PhD) should have a strong background and interest in translational and clinical addiction pharmacology. For additional information, contact: Dr. Lorenzo Leggio email@example.com
Strong verbal and written communication skills are essential. Candidates should have less than 5 years of post-doctoral training. Salary will be set commensurate with experience and accomplishments. Interested candidates should apply by submitting a current C.V. and bibliography, a brief statement of research accomplishments and interests, along with 3 reference contacts. Applications can be submitted electronically or by mail to:
Laboratory of Clinical and Translational Studies
National Institute of Alcohol Abuse and Alcoholism
Mark O. Hatfield Clinical Research Center
Building 10 CRC Room 1-5330
10 Center Drive
Bethesda, Maryland 20892
Att. Dr. Heilig (for the MP Section) or Dr. Leggio (for the CPN Section)
Refer to this website for additional information on both laboratory sections:
The NIH is dedicated to building a diverse community in its training and employment programs. Women, minorities and persons with disabilities are strongly encouraged to apply.
When applying for this position, please mention you saw this ad in the APS Postdoc Exchange.